United Therapeutics Corporation Payments to Acquire Available-for-sale Securities
United Therapeutics Corporation (UTHR) reported Payments to Acquire Available-for-sale Securities of $718.40 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-02-21
- United Therapeutics Corporation payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $265.80M.
- United Therapeutics Corporation payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $156.10M.
- United Therapeutics Corporation payments to acquire available-for-sale securities for fiscal 2017 was $718.40M.
- United Therapeutics Corporation payments to acquire available-for-sale securities for fiscal 2008 was $24.60M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $265.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $421.90M derived: sum of 2 quarters · filed 2018-02-21 | $718.40M 10-K · filed 2018-02-21 | |
| 2017-09-30 | $156.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $452.60M 10-Q · filed 2017-10-25 | ||
| 2017-06-30 | $296.50M 10-Q · filed 2017-07-27 | |||
| 2008-12-31 | $24.60M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |